Andrea S. Porpiglia, MD, Mac

Surgical Oncologist
Department of Surgical Oncology, Fox Chase Cancer Center

Poster(s):

• E118: Beyond Guidelines: The Importance of Optimal Care in Resectable Gastric Cancer

• E119: Survival Impact of National Accreditation Program for Rectal Cancer Treatment Timing Standards

• E23: Immunohistochemical Status Predicts Pathologic Complete Response to Neoadjuvant Therapy in HER2 Overexpressing Breast Cancers

• E376: Adjuvant Therapy After Upfront Resection of T2N0 Gastric Cancer: Is It Necessary?

• E434: Impact of Fragmented Care in Retroperitoneal Sarcomas

• E475: Establishing the Facility Volume to Outcome Relationship for Minimally Invasive Gastrectomy for Gastric Cancer: a National Review of Outcomes